Top

Sleep and Breathing

Published in:

01-03-2022 | Sleep Apnea | Sleep Breathing Physiology and Disorders • Review

Effects of sleep apnea hypopnea syndromes on cardiovascular events: a systematic review and meta-analysis

Authors: Liang Xie, Penghao Zhen, Fuchao Yu, Xiaojin Yu, Hai Qian, Fang Yang, Jiayi Tong

Published in: Sleep and Breathing | Issue 1/2022

Abstract

Purpose

Previous studies suggest that sleep apnea hypopnea syndrome (SAHS) is an independent risk factor that contributes to certain cardiovascular events. However, there are studies arguing that patients with SAHS had lower peak troponin levels when suffering cardiovascular events compared to patients without SAHS, which indicates that there may potentially be a protective effect of SAHS. This meta-analysis aimed to assess the impact of SAHS on cardiovascular events.

Methods

Databases were searched for studies that examined cardiac biomarkers or reported angiographic data when patients with SAHS experienced cardiovascular events. The data about peak cardiac biomarkers and angiographic coronary lesion were extracted and then used to compute the pooled standardized mean difference (SMD) and 95% confidence interval (95% CI).

Results

Among 26 studies included in the meta-analysis, there was not a definite difference between the SAHS group and the control group for troponins (SMD, 0.05; 95% CI, [− 0.16, 0.26]), creatine kinase (SMD, − 0.08; 95% CI, [− 0.38, 0.22]), and CK-MB (SMD, − 0.11; 95% CI, [− 0.51, 0.29]). However, patients with SAHS revealed worse coronary lesion condition grading via both Gensini score (SMD, 0.63; 95% CI, [0.31, 0.95]) and SYNTAX score (SMD, 0.99; 95% CI, [0.31–1.67]).

Conclusions

Ischemic preconditioning induced by the intermittent hypoxia at the early stage could generate a cardiac protection effect, which would then benefit SAHS patients encountering a major adverse cardiovascular event.

Available only for authorised users

Peppard PE, Young T, Barnet JH, Palta M, Hagen EW, Hla KM (2013) Increased prevalence of sleep-disordered breathing in adults. Am J Epidemiol 177(9):1006–1014. https://doi.org/10.1093/aje/kws342CrossRefPubMedPubMedCentral

Tkacova R, McNicholas WT, Javorsky M, Fietze I, Sliwinski P, Parati G, Grote L, Hedner J (2014) Nocturnal intermittent hypoxia predicts prevalent hypertension in the European Sleep Apnoea Database cohort study. Eur Respir J 44(4):931–941. https://doi.org/10.1183/09031936.00225113CrossRefPubMed

Grote L, Hednera J, Peter JH (2000) Sleep-related breathing disorder is an independent risk factor for uncontrolled hypertension. J Hypertens 18(6):679–685CrossRef

Martinez D, Klein C, Rahmeier L, da Silva RP, Fiori CZ, Cassol CM, Goncalves SC, Bos AJG (2012) Sleep apnea is a stronger predictor for coronary heart disease than traditional risk factors. Sleep Breath 16(3):695–701. https://doi.org/10.1007/s11325-011-0559-0CrossRefPubMed

Shamsuzzaman ASM, Gersh BJ, Somers VK (2003) Obstructive sleep apnea: implications for cardiac and vascular disease. J Am Heart Assoc 290(19):1906–1914CrossRef

Peppard PE, Young T, Palta M, Skatrud J (2000) Prospective study of the association between sleep-disordered breathing and hypertension. NEJM 342(19):1378–1384CrossRef

Marshall NS, Wong KKH, Liu PY, Cullen SRJ, Knuiman MW, Grunstein RR (2008) Sleep apnea as an independent risk factor for all-cause mortality: the Busselton Health Study. Sleep 31(8):1079–1085PubMedPubMedCentral

Young T, Finn L, Peppard PE, Szklo-Coxe M, Austin D, Nieto J, Stubbs R, Hla KM (2008) Sleep disordered breathing and mortality: eighteen-year follow-up of the Wisconsin sleep cohort. Sleep 31(8):1071–1078PubMedPubMedCentral

Martinez D, da Silva RP, Klein C, Fiori CZ, Massierer D, Cassol CM, Bos AJ, Gus M (2012) High risk for sleep apnea in the Berlin questionnaire and coronary artery disease. Sleep Breath 16(1):89–94. https://doi.org/10.1007/s11325-010-0460-2CrossRefPubMed

10.

Peker Y, Carlson J, Hedner J (2006) Increased incidence of coronary artery disease in sleep apnoea: a long-term follow-up. Eur Respir J 28(3):596–602. https://doi.org/10.1183/09031936.06.00107805CrossRefPubMed

11.

Shah NA, Yaggi HK, Concato J, Mohsenin V (2010) Obstructive sleep apnea as a risk factor for coronary events or cardiovascular death. Sleep Breath 14(2):131–136. https://doi.org/10.1007/s11325-009-0298-7CrossRefPubMed

12.

Nagayoshi M, Lutsey PL, Benkeser D, Wassel CL, Folsom AR, Shahar E, Iso H, Allison MA, Criqui MH, Redline S (2016) Association of sleep apnea and sleep duration with peripheral artery disease: the Multi-Ethnic Study of Atherosclerosis (MESA). Atherosclerosis 251:467–475. https://doi.org/10.1016/j.atherosclerosis.2016.06.040CrossRefPubMedPubMedCentral

13.

Ghofraniha L, Amini M, Davoudi Y, Eslami S, Layegh P, Lotfi Z, Firouzi F, Khajehnasiri S (2017) The relation of carotid arteries’ intima-media thickness with snoring and obstructive sleep apnea in type 2 diabetes patients. Acta Med Iran 55(12):765–771PubMed

14.

Sanchez-de-la-Torre A, Soler X, Barbe F, Flores M, Maisel A, Malhotra A, Rue M, Bertran S, Aldoma A, Worner F, Valls J, Lee CH, Turino C, Galera E, de Batlle J, Sanchez-de-la-Torre M, Spanish Sleep N (2018) Cardiac troponin values in patients with acute coronary syndrome and sleep apnea: a pilot study. Chest 153(2):329–338. https://doi.org/10.1016/j.chest.2017.06.046CrossRefPubMed

15.

Antman EM, Anbe DT, Armstrong PW, Bates ER, Green LA, Hand M, Hochman JS, Krumholz HM, Kushner FG, Lamas GA, Mullany CJ, Ornato JP, Pearle DL, Sloan MA, Smith SC Jr, Alpert JS, Anderson JL, Faxon DP, Fuster V, Gibbons RJ, Gregoratos G, Halperin JL, Hiratzka LF, Hunt SA, Jacobs AK, Ornato JP (2004) ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction; a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of patients with acute myocardial infarction). J Am Coll Cardiol 44(3):E1–E211. https://doi.org/10.1016/j.jacc.2004.07.014CrossRefPubMed

16.

Gensini GG (1983) A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol 51:606CrossRef

17.

Sianos G, Morel MA, Kappetein AP, Morice MC, Colombo A, Dawkins K, van den Brand M, Van Dyck N, Russell ME, Mohr FW, Serruys PW (2005) The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease. EuroIntervention: Journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 1(2):219-227

18.

Rostom A, Dube C, Cranney A (2004) Celiac Disease (Evidence Reports/Technology Assessments, No. 104). AHRQ Evidence Reports.Appendix D. Quality Assessment Forms. Appendix D. Quality Assessment Forms

19.

Shamseer L, Moher D, Clarke M, Ghersi D, Liberati A, Petticrew M, Shekelle P, Stewart LA, Group P-P (2015) Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ 350:g7647. https://doi.org/10.1136/bmj.g7647CrossRef

20.

Desai R, Broach E, Rochani H, Khaji A, Friedman E, Sardar E (2015) Does ischemic pre-conditioning occur with obstructive sleep apnea (OSA)? Comparing the severity of myocardial necrosis between the patients with OSA and without OSA after an acute st elevation myocardial infarction. Am J Respir Crit Care Med:191. https://doi.org/10.1164/ajrccm-conference.2015.191.1_MeetingAbstracts.A1241

21.

Barbe F, Sanchez-de-la-Torre A, Abad J, Duran-Cantolla J, Mediano O, Amilibia J, Masdeu MJ, Flores M, Barcelo A, de la Pena M, Aldoma A, Worner F, Valls J, Castella G, Sanchez-de-la-Torre M, Spanish Sleep N (2015) Effect of obstructive sleep apnoea on severity and short-term prognosis of acute coronary syndrome. Eur Respir J 45(2):419–427. https://doi.org/10.1183/09031936.00071714CrossRefPubMed

22.

Kukwa W, Glowczynska R, Filipiak KJ, Kukwa A, Opolski G, Budaj-Fidecka A, Grabowski M, Galazka A, Krzeski A, Kuzminska M, Czarnecka AM (2013) Serum EPO and VEGF levels in patients with sleep-disordered breathing and acute myocardial infarction. Sleep Breath 17(3):1063–1069. https://doi.org/10.1007/s11325-013-0801-zCrossRefPubMedPubMedCentral

23.

Caetano F, Madeira M, Sanches I, Martins V, Almeida I, Moita J, Goncalves L (2015) Obstructive sleep apnoea and coronary artery disease: Does non invasive ventilation have prognostic impact? European Heart Journal: Acute Cardiovascular Care 4:52. https://doi.org/10.1177/2048872615599730

24.

Zhang W, Sun Y, Li T, Zhang G, Wang Y, Sun H (2012) The effect of obstructive sleep apnea-hypopnea syndrome on acute myocardial infarction. Bratisl Lek Listy 113(09):565–568. https://doi.org/10.4149/bll_2012_127CrossRefPubMed

25.

Hayashi H, Fukuma N, Kato K, Kato Y, Takahashi H, Mizuno K (2013) Clinical backgrounds and the time course of sleep-disordered breathing in patients after myocardial infarction. J Nippon Med Sch 80(3):192–199CrossRef

26.

Kuniyoshi FH, Garcia-Touchard A, Gami AS, Romero-Corral A, van der Walt C, Pusalavidyasagar S, Kara T, Caples SM, Pressman GS, Vasquez EC, Lopez-Jimenez F, Somers VK (2008) Day-night variation of acute myocardial infarction in obstructive sleep apnea. J Am Coll Cardiol 52(5):343–346. https://doi.org/10.1016/j.jacc.2008.04.027CrossRefPubMed

27.

Lee CH, Khoo SM, Chan MY, Wong HB, Low AF, Phua QH, Richards AM, Tan HC, Yeo TC (2011) Severe obstructive sleep apnea and outcomes following myocardial infarction. J Clin Sleep Med 7(6):616–621. https://doi.org/10.5664/jcsm.1464CrossRefPubMedPubMedCentral

28.

Zhang J, Song Y, Ji Y, Song Y, Cai S, Yu Y, Liu S, Zhang W (2018) Correlation between coronary artery disease and obstructive sleep apnea syndrome and analysis of risk factors. Exp Ther Med 15(6):4771–4776. https://doi.org/10.3892/etm.2018.6070CrossRefPubMedPubMedCentral

29.

Su Y, Li H (2016) Correlation between severity of coronary artery lesions and middle-term prognosis with obstructive sleep apnea-hypopnea syndrome in acute coronary syndrome patients. Chest 149(4):A560. https://doi.org/10.1016/j.chest.2016.02.585

30.

Yao LM (2010) Effects of obstructive sleep apnea on restenosis following coronary artery stent implantation. J Clin Rehabil Tissue Eng Res 14(9):1700–1702. https://doi.org/10.3969/j.issn.1673-8225.2010.09.043

31.

Meng S, Fang L, Wang CQ, Wang LS, Chen MT, Huang XH (2009) Impact of obstructive sleep apnoea on clinical characteristics and outcomes in patients with acute coronary syndrome following percutaneous coronary intervention. J Int Med Res 37(5):1343–1353. https://doi.org/10.1177/147323000903700509

32.

Inami T, Seino Y, Otsuka T, Yamamoto M, Kimata N, Murakami D, Takano M, Ohba T, Ibuki C, Mizuno K (2012) Links between sleep disordered breathing, coronary atherosclerotic burden, and cardiac biomarkers in patients with stable coronary artery disease. J Cardiol 60(3):180–186. https://doi.org/10.1016/j.jjcc.2012.03.003CrossRefPubMed

33.

Long P, Liu J (2014) Obstructive sleep apnea and gensini score in suspected coronary artery disease patients. J Am Coll Cardiol 64(16):C128CrossRef

34.

Vasheghani-Farahani A, Kazemnejad F, Sadeghniiat-Haghighi K, Saadat S, Tavakolipoor P, Yazdani T, Alidoosti M, Ghasem-Amooeian V, Ashraf H (2018) Obstructive sleep apnea and severity of coronary artery disease. Caspian J Intern Med 9(3):276–282. https://doi.org/10.22088/cjim.9.3.276CrossRefPubMedPubMedCentral

35.

Furlan S, Uchoa C, Peres M, Freitas L, Mangione F, Lemos P, Lorenzi-Filho G, Drager L (2016) The obstructive sleep apnea is not associated with increased atherosclerotic burden in patients with coronary disease: a preliminary study. J Sleep Res 25:360–361. https://doi.org/10.1111/jsr.12446CrossRef

36.

Ghazal A, Roghani F, Sadeghi M, Amra B, Kermani-Alghoraishi M (2015) Obstructive sleep apnea, diagnosed by the Berlin questionnaire and association with coronary artery disease severity. ARYA Atheroscler 11(5):275–280PubMedPubMedCentral

37.

Yang D, Liu Z, Luo Q (2013) Plasma ghrelin and pro-inflammatory markers in patients with obstructive sleep apnea and stable coronary heart disease. Med Sci Monit 19(1):251–256. https://doi.org/10.12659/MSM.883874CrossRefPubMedPubMedCentral

38.

Kong L, Guo XH (2009) The relation between obstructive sleep apnea hypopnea syndrome and the severity of coronary atherosclerosis in coronary artery Chinese Journal of General. Surgery 48(8):8

39.

Wen D, Ying P, Zeng X, Zhang Z, Cardiology DO (2015) The relationship between obstructive sleep apnea syndrome and the severity of coronary artery stenosis. Journal of New Medicine

40.

Zhao LP, Kofidis T, Chan SP, Ong TH, Yeo TC, Tan HC, Lee CH (2015) Sleep apnoea and unscheduled re-admission in patients undergoing coronary artery bypass surgery. Atherosclerosis 242(1):128–134. https://doi.org/10.1016/j.atherosclerosis.2015.07.006CrossRefPubMed

41.

Lu G, Xu ZW, Liu JN, Zhang YL, Yang ZJ, Zhang XL, Yin KS (2007) [A study on the association of obstructive sleep apnea hypopnea syndrome with coronary atherosclerosis and coronary heart disease]. Zhonghua Jie He He Hu Xi Za Zhi 30(3):178–181

42.

Huang HF, Chen AM, Shen YY, Qian AB, Yun HF, Xiao B, Lv ZL (2016) The characteristics of coronary lesions and influence factors in eldly patients with both coronary artery disease and obstructive sleep apnea syndrome. Electrocardio Circ 35(01):19–21+28

43.

Calcaianu G, Bresson D, Calcaianu M, Morisset B, El-Nazer T, Deodati C, Virot E, Holtea D, Iamandi C, Debieuvre D (2019) The importance of apneic events in obstructive sleep apnea associated with acute coronary syndrome. Sleep Disord 2019:6039147. https://doi.org/10.1155/2019/6039147

44.

Jia S, Zhou YJ, Yu Y, Wu SJ, Sun Y, Wang ZJ, Liu XL, King BE, Zhao YX, Shi DM, Liu YY, Zhou ZM (2018) Obstructive sleep apnea is associated with severity and long-term prognosis of acute coronary syndrome. J Geriatr Cardiol 15(2):146–152. https://doi.org/10.11909/j.issn.1671-5411.2018.02.005CrossRefPubMedPubMedCentral

45.

Zeng Y, Yang S, Wang X, Fan J, Nie S, Wei Y (2019) Prognostic impact of residual SYNTAX score in patients with obstructive sleep apnea and acute coronary syndrome: a prospective cohort study. Respir Res 20(1):43. https://doi.org/10.1186/s12931-019-1008-zCrossRefPubMedPubMedCentral

46.

Hein T, Loo G, Ng WY, Tai BC, Kajiya T, Tan A, Khoo SM, Chan M, Low AF, Chia BL, Richards M, Lee CH (2013) Relationship between apnoea-hypopnoea index and angiographiccoronary disease phenotypes in patients presenting with acutemyocardial infarction. Acute Card Care 15(2):26–33. https://doi.org/10.3109/17482941.2012.741249CrossRefPubMed

47.

Zhu CP, Li TP, Wang X, Zhao YH, Zhou SX, Fu Y, Jiang YW, Xiao XP (2017) The relationship between apnoea hypopnoea index and Gensini score in patients with acute myocardial infarction undergoing emergency primary percutaneous coronary intervention. J Thorac Dis 9(8):2476–2483. https://doi.org/10.21037/jtd.2017.07.50CrossRefPubMedPubMedCentral

48.

Wan X, Wang WQ, Liu JM, Tong TJ (2014) Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol 14(135):1471–2288

49.

Luo D, Wan X, Liu J, Tong T (2018) Optimally estimating the sample mean from the sample size, median, mid-range, and/or mid-quartile range. Stat Methods Med Res 27(6):1785–1805. https://doi.org/10.1177/0962280216669183CrossRefPubMed

50.

Maeder MT, Strobel W, Christ M, Todd J, Estis J, Wildi K, Thalmann G, Hilti J, Brutsche M, Twerenbold R, Rickli H, Mueller C (2015) Comprehensive biomarker profiling in patients with obstructive sleep apnea. Clin Biochem 48(4-5):340–346. https://doi.org/10.1016/j.clinbiochem.2014.09.005CrossRefPubMed

51.

Einvik G, Rosjo H, Randby A, Namtvedt SK, Hrubos-Strom H, Brynildsen J, Somers VK, Omland T (2014) Severity of obstructive sleep apnea is associated with cardiac troponin I concentrations in a community-based sample: data from the Akershus Sleep Apnea Project. Sleep 37(6):1111–1116, 1116A-1116B. https://doi.org/10.5665/sleep.3772CrossRefPubMedPubMedCentral

52.

Zhang XB, Zeng HQ, Du YP, Lyu Z, Zhan FF (2018) High-sensitivity cardiac troponin T in obstructive sleep apnea patients without cardiovascular diseases: Efficacy of CPAP treatment. Chron Respir Dis 15(2):157–164. https://doi.org/10.1177/1479972317740127

53.

Tikotekar A, Patel C, Karcnik J, Cheng JQ, Kostis J, Hussain S, Sunderram J (2015) Increased incidence of subendocardial infarcts vs transmural infarcts in OSA: analysis of MIDAS database. Am J Respir Crit Care Med 191

54.

Manukhina EB, Jasti D, Vanin AF, Downey HF (2011) Intermittent hypoxia conditioning prevents endothelial dysfunction and improves nitric oxide storage in spontaneously hypertensive rats. Exp Biol Med (Maywood) 236(7):867–873. https://doi.org/10.1258/ebm.2011.011023CrossRef

55.

Manukhina EB, Belkina LM, Terekhina OL, Abramochkin DV, Smirnova EA, Budanova OP, Mallet RT, Downey HF (2013) Normobaric, intermittent hypoxia conditioning is cardio- and vasoprotective in rats. Exp Biol Med (Maywood) 238(12):1413–1420. https://doi.org/10.1177/1535370213508718CrossRef

56.

Wang ZH, Chen YX, Zhang CM, Wu L, Yu Z, Cai XL, Guan Y, Zhou ZN, Yang HT (2011) Intermittent hypobaric hypoxia improves postischemic recovery of myocardial contractile function via redox signaling during early reperfusion. Am J Physiol Heart Circ Physiol 301(4):H1695–H1705. https://doi.org/10.1152/ajpheart.00276.2011CrossRefPubMed

57.

Dong JW, Zhu HF, Zhu WZ, Ding HL, Ma TM, Zhou ZN (2003) Intermittent hypoxia attenuates ischemia/reperfusion induced apoptosis in cardiac myocytes via regulating Bcl-2/Bax expression. Cell Res 13(5):385–391CrossRef

58.

Beguin PC, Belaidi E, Godin-Ribuot D, Levy P, Ribuot C (2007) Intermittent hypoxia-induced delayed cardioprotection is mediated by PKC and triggered by p38 MAP kinase and Erk1/2. J Mol Cell Cardiol 42(2):343–351. https://doi.org/10.1016/j.yjmcc.2006.11.008CrossRefPubMed

59.

Beguin PC, Joyeux-Faure M, Godin-Ribuot D, Levy P, Ribuot C (2005) Acute intermittent hypoxia improves rat myocardium tolerance to ischemia. J Appl Physiol (1985) 99(3):1064–1069. https://doi.org/10.1152/japplphysiol.00056.2005CrossRef

60.

Cai Z, Manalo DJ, Wei G, Rodriguez ER, Fox-Talbot K, Lu H, Zweier JL, Semenza GL (2003) Hearts from rodents exposed to intermittent hypoxia or erythropoietin are protected against ischemia-reperfusion injury. Circulation 108(1):79–85. https://doi.org/10.1161/01.CIR.0000078635.89229.8ACrossRefPubMed

61.

Ben Ahmed H, Boussaid H, Longo S, Tlili R, Fazaa S, Baccar H, Boujnah MR (2015) Impact of obstructive sleep apnea in recruitment of coronary collaterality during inaugural acute myocardial infarction. Ann Cardiol Angeiol (Paris) 64(4):273–278. https://doi.org/10.1016/j.ancard.2015.01.014CrossRef

62.

Steiner S, Schueller PO, Schulze V, Strauer BE (2010) Occurrence of coronary collateral vessels in patients with sleep apnea and total coronary occlusion. Chest 137(3):516–520. https://doi.org/10.1378/chest.09-1136CrossRefPubMed

Title: Effects of sleep apnea hypopnea syndromes on cardiovascular events: a systematic review and meta-analysis
Authors: Liang Xie
Penghao Zhen
Fuchao Yu
Xiaojin Yu
Hai Qian
Fang Yang
Jiayi Tong
Publication date: 01-03-2022
Publisher: Springer International Publishing
Keywords: Sleep Apnea
Angiography
Polysomnography
Biomarkers
Published in: Sleep and Breathing / Issue 1/2022
Print ISSN: 1520-9512
Electronic ISSN: 1522-1709
DOI: https://doi.org/10.1007/s11325-021-02294-3

ACC 2024 Congress Coverage

Heart Failure Video

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Effects of sleep apnea hypopnea syndromes on cardiovascular events: a systematic review and meta-analysis

Abstract

Purpose

Methods

Results

Conclusions

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2022

Analysis of the proportion and clinical characteristics of obstructive sleep apnea in women with polycystic ovary syndrome

7,8-Dihydroxyflavone protects retinal ganglion cells against chronic intermittent hypoxia-induced oxidative stress damage via activation of the BDNF/TrkB signaling pathway

Cerebellar malfunction and postoperative sleep disturbances after general anesthesia: a narrative review

The acoustical and perceptual features of snore-related sounds in patients with obstructive sleep apnea sleeping with the dynamic mandibular advancement system MATRx plus®

Impact of the sleep apnea management group clinic on positive airway pressure adherence

Comorbidity clusters in patients with moderate-to-severe OSA

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page